Aurinia Pharmaceuticals Inc (AUPH) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Aurinia Pharmaceuticals Inc · Cost of Revenue

AUPH Cost of Revenue

Latest reported$30.04Mperiod endingJun 30, 2026

AUPH Cost of Revenue ($520.83K → $30.04M)

Annual cost of revenue

High-resolution chart · PNG

AUPH cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	32,665,000
Dec 31, 2024	28,248,000
Dec 31, 2023	14,148,000
Dec 31, 2022	5,664,000
Dec 31, 2021	1,091,000
Dec 31, 2020	0
Dec 31, 2019	0
Dec 31, 2018	41,382,000
Dec 31, 2017	1,000
Dec 31, 2016	4,000
Dec 31, 2015	12,000
Dec 31, 2014	37,000
Dec 31, 2013	939
Dec 31, 2012	46,239
Dec 31, 2011	185,112
Dec 31, 2010	50,991
Dec 31, 2009	575,876
Dec 31, 2008	2,115,036
Dec 31, 2007	1,050,186
Dec 31, 2006	597,117
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	686,014
Dec 31, 2001	1,025,138
Nov 30, 2000	680,662
Nov 30, 1999	679,098
Nov 30, 1998	520,833

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.